StemPar Sciences Secures Initial Funding For Its Novel Cancer Metabolism Drugs
02 janv. 2013 09h00 HE
|
Stempar Sciences
San Francisco, CA, Jan. 2, 2013 (GLOBE NEWSWIRE) -- Privately held StemPar Sciences, Inc. today announced an initial
investment from Troika Venture Capital, a multi-profile
international venture...